-
Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))
Hollander, B. D., Rothuizen-Lindenschot, M., Geertjens, L., Vaz, F. M., Brands, M. M., Le, H. L., van Eeghen, A. M., van de Ven, P. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H. & van Karnebeek, C. D., Apr 2024, In: Contemporary Clinical Trials Communications. 38, p. 101264 101264.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Mechanism-based interventions for ASD cannot be implemented using conventional trial designs
Sprengers, J. J., Geertjens, L. & Bruining, H., Feb 2024, In: Autism research. 17, 2, p. 202-203 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
-
Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol: BUDDI protocol
Geertjens, L., Cristian, G., Haspels, E., Ramautar, J., van der Wilt, G. J., Verhage, M. & Bruining, H., 7 Jul 2022, In: BMC psychiatry. 22, 1, p. 1-11 11 p., 452.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
